HCM Academy is an independent educational initiative supported by grant funding from Bristol Myers Squibb, Cytokinetics, iRhythm Technologies, Sanofi and Tenaya Therapeutics. PCM Scientific is the organiser and all content is created by the faculty. No funder has had input into any content or activity.

Abstract Library

Abstract library - real-world evidence

Although randomized–controlled trials are the clinical gold standard, they are not without limitations. Evidence from the real world can be used together with clinical trial data to support our understanding of HCM is managed in practice and how decisions affect patient management. By looking at both clinical trials and real-world evidence, we build a robust picture of the clinical landscape of HCM.